在COPD中,Smad7通过调节上皮层-介质细胞过渡来改善小气道重塑
Xianyang Liu1, Shenghua Sun1, Shengyang He2,3,4,5
1Department of Pulmonary and Critical Care Medicine, The Third Xiangya Hospital of Central South University, Changsha, China.
Tobacco induced diseases
|November 3, 2025
概括
吸烟驱动慢性阻塞性肺病 (COPD) 中的小气道重塑,通过表皮-介质细胞过渡 (EMT). Smad7,一个关键的调节器,有效地抑制了吸烟引起的EMT过程.
科学领域:
- 肺部医学 肺部医学
- 细胞生物学 细胞生物学
- 疾病的分子机制.
背景情况:
- 小气道改造是慢性阻塞性肺病 (COPD) 的一个关键,但不太了解的方面.
- 转化生长因子-β1 (TGF-β1) 通过诱导上皮层-介质细胞过渡 (EMT) 参与了呼吸道重塑.
- 作为TGF-β信号传递的负调节者,Smad7在COPD病变发生过程中的作用目前尚不确定.
研究的目的:
- 在COPD小气道改造的背景下,调查Smad7在抑制TGF-β1诱导的EMT中的作用.
- 阐明吸烟,TGF-β1,EMT和COPD中呼吸道重塑之间的分子机制.
主要方法:
- 分析了COPD患者的肺组织和EMT标记物和原沉积的小鼠模型.
- 使用暴露于香烟烟雾提取物 (CSE) 的BEAS-2B细胞进行体外研究,通过RT-qPCR,西斑和免疫光来评估TGF-β1分泌和EMT标记物 (E-Cadherin,N-Cadherin,Vimentin).
- 通过过度表达和敲击实验来评估Smad7的功能.
主要成果:
- 慢性肺炎患者和小鼠模型表现出高EMT和原沉积,表明呼吸道重塑.
- 在BEAS-2B细胞中,CSE暴露增加了TGF-β1,减少了E-Cadherin,增加了N-Cadherin和Vimentin,证实了EMT诱导.
- Smad7的过度表达逆转了CSE诱导的EMT标记和形态变化,而Smad7的淘汰则加剧了这些影响.
结论:
- 吸烟通过驱动EMT显著促进COPD中TGF-β1诱导的小气道重塑.
- Smad7作为吸烟诱导的EMT通路的关键抑制剂,提供了一个潜在的治疗点.
更多相关视频
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
01:26COPD: Management Using Bronchodilators and Corticosteroids
713
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
713
01:20COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
01:22Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K